TNA
True North Advisors’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.3M | Sell |
2,956
-399
| -12% | -$311K | 0.44% | 52 |
|
|
2025
Q1 | $2.77M | Sell |
3,355
-128
| -4% | -$106K | 0.49% | 48 |
|
|
2024
Q4 | $2.69M | Buy |
3,483
+258
| +8% | +$199K | 0.63% | 36 |
|
|
2024
Q3 | $2.86M | Sell |
3,225
-42
| -1% | -$37.2K | 0.75% | 23 |
|
|
2024
Q2 | $2.96M | Sell |
3,267
-1,042
| -24% | -$943K | 0.79% | 23 |
|
|
2024
Q1 | $3.35M | Buy |
4,309
+18
| +0.4% | +$14K | 0.93% | 17 |
|
|
2023
Q4 | $2.5M | Sell |
4,291
-114
| -3% | -$66.5K | 0.64% | 24 |
|
|
2023
Q3 | $2.37M | Sell |
4,405
-1,081
| -20% | -$581K | 0.73% | 21 |
|
|
2023
Q2 | $2.57M | Buy |
5,486
+316
| +6% | +$148K | 0.73% | 26 |
|
|
2023
Q1 | $1.78M | Buy |
5,170
+670
| +15% | +$230K | 0.52% | 45 |
|
|
2022
Q4 | $1.65M | Hold |
4,500
| – | – | 0.56% | 43 |
|
|
2022
Q3 | $1.46M | Sell |
4,500
-138
| -3% | -$44.6K | 0.48% | 51 |
|
|
2022
Q2 | $1.5M | Buy |
4,638
+174
| +4% | +$56.4K | 0.47% | 52 |
|
|
2022
Q1 | $1.28M | Buy |
4,464
+758
| +20% | +$217K | 0.34% | 69 |
|
|
2021
Q4 | $1.02M | Buy |
3,706
+68
| +2% | +$18.8K | 0.17% | 111 |
|
|
2021
Q3 | $840K | Buy |
3,638
+42
| +1% | +$9.7K | 0.17% | 115 |
|
|
2021
Q2 | $825K | Sell |
3,596
-41
| -1% | -$9.41K | 0.17% | 109 |
|
|
2021
Q1 | $679K | Buy |
3,637
+182
| +5% | +$34K | 0.16% | 108 |
|
|
2020
Q4 | $583K | Sell |
3,455
-193
| -5% | -$32.6K | 0.15% | 108 |
|
|
2020
Q3 | $539K | Buy |
3,648
+346
| +10% | +$51.1K | 0.16% | 102 |
|
|
2020
Q2 | $542K | Buy |
+3,302
| New | +$542K | 0.13% | 112 |
|